Riskpilot← Back to searchSign inGet full accessDoktor Philippe Kopylov AB
ABActiveOrg 5565191417Fader Bergs Väg 1General medical practice activities · NACE 8621Est. 19951-4 employees
Revenue 2024
SEK 1,2M
0% vs 2023
EBITDA margin
34.4%
+13% vs 2023
Equity ratio
57.7%
Financial strength
Net profit 2024
SEK 304K
+11% vs 2023
| Revenue | SEK 1,2M | +0% |
| EBITDA | SEK 396K | +13% |
| Net profit | SEK 304K | +11% |
| Total assets | SEK 735K | +0% |
| Equity | SEK 424K | +8% |
| Employees | — | — |
Legal name
Doktor Philippe Kopylov AB
Org number
5565191417
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
12 juli 1995
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarpraktik, medicinsk forskning och utbildning, handel med konst och värdepapper samt äga och förvalta fast egendom ävensom idka därmed förenlig verksamhet.
Address
Fader Bergs Väg 1
Phone
+46708126752
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 008 | 911 | 952 | 1 157 | 1 152 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 283 | 206 | 371 | 352 | 396 |
| Depreciation & amort. | −5 | −5 | −5 | −5 | −5 |
| EBIT | 278 | 201 | 366 | 347 | 391 |
| Net financials | — | — | — | 1 | 1 |
| Profit before tax | 278 | 201 | 366 | 347 | 391 |
| Tax | −65 | −43 | −80 | −74 | −87 |
| Net profit | 213 | 158 | 286 | 273 | 304 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 643 | 557 | 677 | 736 | 735 |
| Equity | 335 | 278 | 406 | 394 | 424 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 307 | 279 | 272 | 342 | 311 |
| Total debt | 307 | 279 | 272 | 342 | 311 |
EBITDA margin
34.4%
This company
15.8%
Market median
+118% vs market
20202024
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
20202024
Return on equity
71.7%
This company
18.4%
Market median
+290% vs market
20202024
Net profit margin
26.4%
This company
8.1%
Market median
+226% vs market
20202024
Asset turnover
1.57×
This company
1.12×
Market median
+40% vs market
20202024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PJ Audit | Audit | 2024 |
| Former (1) | ||
HG | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doktor Philippe Kopylov AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Georg Bo Ehrlinder | Audit | 0 companies |
| Per Johan Lidehäll | Audit | 0 companies |
| Philippe Kopylov | Board of Directors | 0 companies |
| Chrissanti Kopylov | Deputy Board Member | 0 companies |